In vitro methods to assess drug precipitation in the fasted small intestine – a PEARRL review

dc.accessRightsAnonymous
dc.audienceScience
dc.contributor.authorO'Dwyer, Patrick J.
dc.contributor.authorLitou, Chara
dc.contributor.authorBox, Karl, J.
dc.contributor.authorDressman, Jennifer
dc.contributor.authorKostewicz, Edmund, S.
dc.contributor.authorKuentz, Martin
dc.contributor.authorReppas, Christos
dc.date.accessioned2019-01-25T08:27:35Z
dc.date.available2019-01-25T08:27:35Z
dc.date.issued2018-06
dc.description.abstractObjectives Drug precipitation in vivo poses a significant challenge for the pharmaceutical industry. During the drug development process, the impact of drug supersaturation or precipitation on the in vivo behaviour of drug products is evaluated with in vitro techniques. This review focuses on the small and full scale in vitro methods to assess drug precipitation in the fasted small intestine. Key findings Many methods have been developed in an attempt to evaluate drug precipitation in the fasted state, with varying degrees of complexity and scale. In early stages of drug development, when drug quantities are typically limited, small‐scale tests facilitate an early evaluation of the potential precipitation risk in vivo and allow rapid screening of prototype formulations. At later stages of formulation development, full‐scale methods are necessary to predict the behaviour of formulations at clinically relevant doses. Multicompartment models allow the evaluation of drug precipitation after transfer from stomach to the upper small intestine. Optimisation of available biopharmaceutics tools for evaluating precipitation in the fasted small intestine is crucial for accelerating the development of novel breakthrough medicines and reducing the development costs. Summary Despite the progress from compendial quality control dissolution methods, further work is required to validate the usefulness of proposed setups and to increase their biorelevance, particularly in simulating the absorption of drug along the intestinal lumen. Coupling results from in vitro testing with physiologically based pharmacokinetic modelling holds significant promise and requires further evaluation.
dc.identifier.doihttps://doi.org/10.1111/jphp.12951
dc.identifier.issn0022-3573
dc.identifier.issn2042-7158
dc.identifier.urihttp://hdl.handle.net/11654/27327
dc.language.isoen
dc.publisherWileyen_US
dc.relation.ispartofJournal of Pharmacy and Pharmacologyen_US
dc.subjectbiorelevant
dc.subjectin vitro techniques
dc.subjectoral drug absorption
dc.subjectpecipitation
dc.subjectsupersaturation
dc.titleIn vitro methods to assess drug precipitation in the fasted small intestine – a PEARRL review
dc.type01A - Beitrag in wissenschaftlicher Zeitschrift
dc.volume71
dspace.entity.typePublication
fhnw.InventedHereYes
fhnw.IsStudentsWorkno
fhnw.PublishedSwitzerlandNo
fhnw.ReviewTypeAnonymous ex ante peer review of a complete publication
fhnw.affiliation.hochschuleHochschule für Life Sciencesde_CH
fhnw.affiliation.institutInstitut für Pharma Technologyde_CH
fhnw.publicationOnlineJa
fhnw.publicationStatePublished
relation.isAuthorOfPublication68819448-8611-488b-87bc-1b1cf9a6a1b4
relation.isAuthorOfPublication.latestForDiscovery68819448-8611-488b-87bc-1b1cf9a6a1b4
Dateien